Edition:
United States

Profile: Akorn Inc (AKRX.O)

AKRX.O on Nasdaq

33.06USD
22 Sep 2017
Change (% chg)

-- (--)
Prev Close
$33.06
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,247,101
52-wk High
$34.00
52-wk Low
$17.61

Akorn Inc. (Akorn), together with its subsidiaries, is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments: Prescription Pharmaceuticals and the Consumer Health. The Prescription Pharmaceuticals segment consists of generic and branded prescription pharmaceuticals in a range of dosage forms, including sterile ophthalmics, injectables and inhalants and non-sterile oral liquids, topicals and nasal sprays and otics. The Consumer Health segment consists of branded and private-label OTC products and animal health products dispensed by veterinary professionals. Its branded and private-label OTC products are focused on ophthalmics, including a dry eye treatment TheraTears Therapy for Your Eyes.

Company Address

Akorn Inc

1925 W Field Ct Ste 300
LAKE FOREST   IL   60045-4862
P: +1847.2796100
F: +1800.9433694

Company Web Links